Inducible Expression of Protein F14
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Cambridge
Other organizations : Wellcome/Cancer Research UK Gurdon Institute
Variable analysis
- Transfection of pcDNA4/TO-coF14-TAP plasmid encoding F14 under the control of the HCMV immediate early promoter and two tetracycline operator (TetO2) sites
- Expression of protein F14 within the clonal cell lines, analyzed by immunoblotting and flow cytometry with anti-FLAG antibodies
- T-REx-293 cells (Invitrogen), which constitutively expresses the Tet repressor (TetR)
- Selection of transfected cells in the presence of blasticidin (10 μg ml-1) and zeocin (100 μg ml-1)
- Clonal cell lines obtained by limiting dilution
- T-REx-293-EV, T-REx-293-B14 and T-REx-293-C6 cell lines described elsewhere
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!